About Ronald Martell
Form D filings for MorphImmune from 2022 to 2023 list Ronald Martell as director.
Ronald Martell first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Ronald Martell in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Ronald Martell works with at each company, as listed on that company's latest Form D.
MorphImmune Inc. · Form D, May 17, 2023
SD
Sunil Singhal, M.D.
Director
PD
Philip Low, Ph.D.
Director
IB
Isaac Barchas
Director
CD
Clay Siegall, Ph.D.
President and Chief Executive Officer, director
FD